Your browser doesn't support javascript.
loading
Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.
Aung, Phyu P; Nagarajan, Priyadharsini; Tetzlaff, Michael T; Curry, Jonathan L; Tang, Guilin; Abdullaev, Zied; Pack, Svetlana D; Ivan, Doina; Prieto, Victor G; Torres-Cabala, Carlos A.
Afiliación
  • Aung PP; Assistant Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Nagarajan P; Assistant Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tetzlaff MT; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Curry JL; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tang G; Associate Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Abdullaev Z; Assistant Professor, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pack SD; Molecular Biologist, Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
  • Ivan D; Staff Scientist, Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
  • Prieto VG; Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Torres-Cabala CA; Associate Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Am J Dermatopathol ; 41(3): 167-179, 2019 Mar.
Article en En | MEDLINE | ID: mdl-30801340
The presence of multiple BAP1-negative melanocytic neoplasms is a hallmark of familial cancer susceptibility syndrome caused by germline mutations in BAP1. Melanocytic tumors lacking BAP1 expression may also present as sporadic lesions in patients lacking a germline BAP1 mutation. Here, we report histomorphologic and clinical characteristics of cutaneous melanomas with loss of BAP1 expression in 4 patients with no known history of BAP1-associated cancer susceptibility syndrome. The lesions were nodular melanomas composed predominantly of intradermal large epithelioid (Spitzoid) melanocytes with nuclear pseudoinclusions as well as scattered multinucleated cells, arising in association with a typical intradermal nevus. Of the 4 patients, only 1 had recurrence. This patient had multiple recurrences with in-transit and regional lymph node metastases. To the best of our knowledge, this is the first reported series of cutaneous melanomas with loss of BAP1 expression arising in patients without a family history of cancer.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Proteínas Supresoras de Tumor / Ubiquitina Tiolesterasa / Melanoma Tipo de estudio: Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Dermatopathol Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Proteínas Supresoras de Tumor / Ubiquitina Tiolesterasa / Melanoma Tipo de estudio: Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Dermatopathol Año: 2019 Tipo del documento: Article